Stem cells blamed for cancer re-growth
It can also lead to the development of new forms of treatment that targets stem cells that cause tumours to reappear after cancer therapy.
Three different scientific papers by different researchers were published simultaneously in the journals Nature and Science. All three studies, conducted on mice, present evidence on the existence of cancer stem cells.
“The hypothesis (that cancer stem cells exist) has been around now for some time. Hopefully these three papers now make an end to the discussion,” Hugo Snippert from the University Medical Centre Utrecht said in an AFP report.
Some experts believed that tumours comprised of masses of cancer cells that are all the same, but Snippert said the latest papers clearly show a hierarchy of cells in tumours, with different functions – including stem cells that act as cancer cell factories.
Snippert, whose team focused on intestinal cancer, explained that a healthy stem cell mutates to create a “cell of origin” from which a tumour grows. The tumour contains stem cells which then create new cancer cells.
A research team of the University of Texas Southwestern Medical Centre that focused on incurable brain tumours, said they had found a subset of cells that appear to be the source of new tumour growth after chemotherapy.
A separate team in Belgium and the UK found a sub-population of tumour cells with stem-like properties in skin cancer.
“Taken together these reports provide evidence that point towards the existence of cells that may represent cancer stem cells,” said a Nature press statement.
Cancer stem cells must now be targeted for drug research.
Source: Sapa, AFP
Author
-
Health-e News is South Africa's dedicated health news service and home to OurHealth citizen journalism. Follow us on Twitter @HealtheNews
View all posts
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
-
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
-
You must include all of the links from our story, including our newsletter sign up link.
-
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
-
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
-
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
-
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
-
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Stem cells blamed for cancer re-growth
by Health-e News, Health-e News
August 2, 2012